Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,883 | 113 | 96.4% |
| Education | $71.04 | 2 | 3.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech USA, Inc. | $209.96 | 13 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $203.85 | 12 | $0 (2023) |
| Amgen Inc. | $143.72 | 9 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $143.31 | 7 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $123.53 | 9 | $0 (2019) |
| Pharmacyclics LLC, An AbbVie Company | $106.37 | 4 | $0 (2019) |
| PFIZER INC. | $100.48 | 7 | $0 (2023) |
| Merck Sharp & Dohme Corporation | $94.17 | 6 | $0 (2020) |
| Bayer Healthcare Pharmaceuticals Inc. | $79.08 | 5 | $0 (2023) |
| Janssen Biotech, Inc. | $74.72 | 4 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $261.71 | 11 | Novartis Pharmaceuticals Corporation ($54.45) |
| 2020 | $102.19 | 7 | Merck Sharp & Dohme Corporation ($28.78) |
| 2019 | $478.18 | 33 | Amgen Inc. ($61.11) |
| 2018 | $397.71 | 28 | Genentech USA, Inc. ($70.27) |
| 2017 | $714.26 | 36 | Genentech USA, Inc. ($96.95) |
All Payment Transactions
115 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/20/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | GILOTRIF (Drug) | Food and Beverage | In-kind items and services | $27.87 | General |
| Category: ONCOLOGY | ||||||
| 10/09/2023 | PFIZER INC. | IBRANCE (Drug), COMIRNATY | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: ONCOLOGY | ||||||
| 10/05/2023 | SOBI, INC | Doptelet (Drug) | Food and Beverage | In-kind items and services | $25.04 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 10/04/2023 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $22.57 | General |
| Category: Oncology | ||||||
| 10/03/2023 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: Oncology | ||||||
| 09/21/2023 | Novartis Pharmaceuticals Corporation | LOCAMETZ (Drug), PLUVICTO | Food and Beverage | In-kind items and services | $25.85 | General |
| Category: Oncology | ||||||
| 09/20/2023 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $22.43 | General |
| Category: Oncology | ||||||
| 09/18/2023 | Mirati Therapeutics, Inc. | KRAZATI (Drug) | Food and Beverage | In-kind items and services | $25.67 | General |
| Category: ONCOLOGY | ||||||
| 09/06/2023 | Lilly USA, LLC | VERZENIO (Drug) | Food and Beverage | In-kind items and services | $23.51 | General |
| Category: Oncology | ||||||
| 08/31/2023 | Novartis Pharmaceuticals Corporation | LUTATHERA (Drug), PLUVICTO | Food and Beverage | In-kind items and services | $28.60 | General |
| Category: Oncology | ||||||
| 08/30/2023 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Food and Beverage | In-kind items and services | $23.28 | General |
| Category: Oncology | ||||||
| 03/10/2020 | Teva Pharmaceuticals USA, Inc. | BENDEKA (Drug) | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: Oncology | ||||||
| 03/04/2020 | Kite Pharma, Inc. | Yescarta (Drug) | Food and Beverage | In-kind items and services | $12.45 | General |
| Category: CELLT | ||||||
| 02/25/2020 | PFIZER INC. | IBRANCE (Drug), TALZENNA | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: ONCOLOGY | ||||||
| 02/12/2020 | Bayer HealthCare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: Oncology | ||||||
| 02/05/2020 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $14.12 | General |
| 01/29/2020 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: ONCOLOGY | ||||||
| 01/22/2020 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: ONCOLOGY | ||||||
| 12/11/2019 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $14.93 | General |
| Category: Hematology/Oncology | ||||||
| 12/04/2019 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: ONCOLOGY | ||||||
| 11/27/2019 | PFIZER INC. | BAVENCIO (Drug), LORBRENA, BRAFTOVI | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: ONCOLOGY | ||||||
| 11/21/2019 | Taiho Oncology, Inc. | Lonsurf (Drug) | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: Oncology | ||||||
| 11/13/2019 | Genentech USA, Inc. | Alecensa (Biological), TECENTRIQ, ROZLYTREK | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: BioOncology | ||||||
| 11/06/2019 | Bayer HealthCare Pharmaceuticals Inc. | Vitrakvi (Drug) | Food and Beverage | In-kind items and services | $12.39 | General |
| Category: Oncology | ||||||
| 10/30/2019 | AstraZeneca Pharmaceuticals LP | IMFINZI (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 6 | 150 | 178 | $65,390 | $16,291 |
| 2020 | 6 | 183 | 333 | $37,134 | $19,289 |
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 46 | 53 | $23,055 | $5,748 | 24.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 44 | 56 | $17,360 | $4,273 | 24.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 24 | 24 | $13,560 | $3,452 | 25.5% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 12 | 12 | $5,340 | $1,286 | 24.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 13 | 17 | $3,995 | $1,015 | 25.4% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 11 | 16 | $2,080 | $517.19 | 24.9% |
| G9678 | Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a | Office | 2020 | 24 | 74 | $11,840 | $11,629 | 98.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 44 | 50 | $12,250 | $3,915 | 32.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 33 | 53 | $8,745 | $2,651 | 30.3% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2020 | 41 | 69 | $1,725 | $525.09 | 30.4% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 13 | 38 | $2,280 | $424.71 | 18.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 28 | 49 | $294.00 | $144.06 | 49.0% |
About Dr. Usha Niranjan, M.D
Dr. Usha Niranjan, M.D is a Specialist healthcare provider based in Red Bank, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/07/2005. The National Provider Identifier (NPI) number assigned to this provider is 1396733077.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Usha Niranjan, M.D has received a total of $1,954 in payments from pharmaceutical and medical device companies, with $261.71 received in 2023. These payments were reported across 115 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($1,883).
As a Medicare-enrolled provider, Niranjan has provided services to 333 Medicare beneficiaries, totaling 511 services with total Medicare billing of $35,580. Data is available for 2 years (2020–2022), covering 12 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Other Specialties Medical Oncology
- Location Red Bank, NJ
- Active Since 10/07/2005
- Last Updated 12/16/2024
- Taxonomy Code 174400000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1396733077
Products in Payments
- Imbruvica (Drug) $106.37
- OPDIVO (Biological) $101.77
- IMFINZI (Drug) $82.73
- KEYTRUDA (Biological) $80.05
- Neulasta (Biological) $66.84
- Perjeta (Biological) $66.33
- TECENTRIQ (Biological) $64.73
- DARZALEX (Biological) $60.90
- IBRANCE (Drug) $60.21
- KISQALI (Drug) $56.28
- Xtandi (Drug) $55.31
- TAGRISSO (Drug) $48.20
- JAKAFI (Drug) $46.13
- GILOTRIF (Drug) $42.87
- SANCUSO (Drug) $42.26
- CYRAMZA (Drug) $38.38
- Nubeqa (Drug) $36.61
- ZEJULA (Drug) $36.09
- Avastin (Biological) $34.98
- JEVTANA (Drug) $33.43
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Red Bank
Dr. Richard Haddad, Md, MD
Specialist — Payments: $1.5M
Dr. Edward Allegra, Md, MD
Specialist — Payments: $273,313
Dr. Diana Trusky, Md, MD
Specialist — Payments: $1,387
Mr. Robert Gabel, Md, MD
Specialist — Payments: $414.30
Dr. Thomas Theocharides, Md, MD
Specialist — Payments: $339.86
Dr. Frederick Stone, M.d, M.D
Specialist